PASSReviewer 1· 92% conf
The manuscript reports thoroughly: registration, CONSORT adherence, funding/COI, limitations, and proportional conclusions.
Evidence
direct quote[Methods, Study Design]
“This report adheres to the guidelines for Consolidated Standards of Reporting Trials.”direct quote[Abstract]
“ClinicalTrials.gov (http://ClinicalTrials.gov) NCT05391230”direct quote[Funding]
“Funding for the trial was provided by a Clinical Scientist Development Award to RMB from the Doris Duke Foundation (Award 24971).”PASSReviewer 2· 90% conf
Reporting is transparent overall: methods are complete, trial is registered, reporting guideline is followed, limitations are discussed, and conclusions are proportional. However, not all secondary outcomes are reported in this paper, and a conflict of interest statement is missing.
Evidence
direct quote[Abstract]
“ClinicalTrials.gov (http://ClinicalTrials.gov) NCT05391230 (https://clinicaltrials.gov/ct2/show/NCT05391230)”direct quote[Methods, Outcomes and Results]
“Molecular testing for asymptomatic parasitemia and analysis of maternal outcomes is ongoing and will be reported separately.”absence[Funding section and end of manuscript]
No explicit conflict of interest statement is present.PASSReviewer 3· 90% conf
Most reporting transparency criteria are met: methods are complete, trial is registered, reporting guideline is followed, limitations are discussed, and conclusions are proportional. However, not all pre-specified outcomes are reported in this paper (some are pending), and a conflicts-of-interest statement is absent.
Evidence
direct quote[Abstract and Methods]
“ClinicalTrials.gov (http://ClinicalTrials.gov) NCT05391230”direct quote[Methods, Outcomes]
“Molecular testing for asymptomatic parasitemia and analysis of maternal outcomes is ongoing and will be reported separately.”absence[Acknowledgements and throughout]
No conflicts-of-interest statement is found.